Erik Lium, PhD, an expert in academic-industry partnerships and commercializing early-stage scientific discoveries, has joined the Mount Sinai Health System as Vice President and Executive Director of Mount Sinai Innovation Partners (MSIP). In this role, Dr. Lium leads MSIP’s efforts to foster collaborative partnerships with pharmaceutical, medical device, diagnostic, and information technology companies, and to commercialize Mount Sinai discoveries.
Faculty from throughout the Mount Sinai Health System joined residents, and medical and graduate students, at a recent social event sponsored by Friends of Odysseus, a black male mentoring program established in 2012 at the behest of Mount Sinai leadership to assist with the recruitment, retention, and promotion of black and Hispanic males in the sciences and medicine.
“I thought I would never live to see the end of that day,” said Mount Sinai Beth Israel patient Robert Cohen, recollecting his experience as a young U.S. infantryman landing on Utah Beach on June 6, 1944. Mr. Cohen spent the 70th anniversary of the D-Day landing with Alene, his wife of 66 years, his son Michael, two of his eight grandchildren, and Mount Sinai Beth Israel staff, discussing the events of that day, when he was one of 20,000 Allied troops landing at Utah Beach, the westernmost flank of the Normandy invasion.
A novel vaccine that stimulates the body’s immune response has been effective in shrinking tumors in patients with low-grade, B-cell lymphoma. Two patients enrolled in a clinical trial at The Tisch Cancer Institute at the Mount Sinai Health System experienced partial remissions of their disease within six months after completing treatment.
The federal Centers for Medicare and Medicaid Services (CMS) has awarded $9.6 million to Icahn School of Medicine at Mount Sinai to establish a Mobile Acute Care Team (MACT) program that provides patients with eligible medical conditions the same level of acute care they would receive in the hospital, but in their home environment.
Peter Palese, PhD, a world-renowned microbiologist who has led seminal studies that continue to greatly expand the understanding of influenza viruses, was recently named a member of the 2014 class of the American Academy of Arts and Sciences. The organization is one of the nation’s most acclaimed honorary societies and a leading center for independent policy research. It includes among its current members more than 250 Nobel Laureates across disciplines and more than 60 Pulitzer Prize winners.
The Office for Diversity and Inclusion invites all Mount Sinai Health System employees, family members, and friends to march with Mount Sinai in the New York City Pride Parade. RSVP at http://tiny.cc/SinaiPrideParade2014.
Mount Sinai marchers must register to receive specific event details, including meeting time and locations.
A commitment to excellence in clinical practice and patient satisfaction were central themes at six Town Hall meetings in April and May, when leaders from the Mount Sinai Health System met with faculty and staff from each hospital to discuss the institution’s strategic direction and answer questions about its integration.
The meetings—which included question-and-answer sessions—summed up the progress that has been made since The Mount Sinai Medical Center combined with Continuum Health Partners last fall.
The United States Permanent Representative to the United Nations; a Nobel Laureate; a pioneering cancer researcher and champion of women scientists; and a leading physician and medical journalist were among those honored at the 45th annual Commencement of the Icahn School of Medicine at Mount Sinai, held Friday, May 9, at Avery Fisher Hall.
The New York State Department of Health recently awarded The Mount Sinai Hospital’s Cardiac Catheterization (Cath) Laboratory the highest “two-star” safety rating for percutaneous coronary interventions (PCI) in overall and nonemergency cases. This marks the 16th consecutive year that the Cath Lab, or one of its physicians, has received this prestigious two-star rating for safety when performing PCI. The minimally invasive procedure, also known as angioplasty, is used to diagnose and treat patients with heart disease or blocked arteries.